QUARTERLY M&A ACTIVITY: The second quarter of 2024 marked a dynamic period for Oaklins with 62 closed transactions. This activity underscores the a...
Read articleQUARTERLY M&A ACTIVITY: The second quarter of 2024 marked a dynamic period for Oaklins with 62 closed transactions. This activity underscores the a...
Read articleQUARTERLY M&A ACTIVITY: Q1 saw a dynamic market with significant M&A activity in various industries, with TMT leading with 15 deals. Energy, Real E...
Read articleQUARTERLY M&A ACTIVITY: Oaklins has proven its adaptability and strategic acumen in a challenging market, completing 87 transactions in Q4 and clim...
Read articleJULYl AND AUGUST M&A ACTIVITY: We successfully concluded 38 transactions, of which the majority were sell-side. Notably, over 75% of the transactio...
Read articleARTIFICIAL INTELLIGENCE WEBINAR
Read articleMAY DEAL ACTIVITY: Amidst challenging market conditions, Oaklins sees M&A as a vital corporate strategy to build resilience and outperform competit...
Read articleDEAL FLASH: Oaklins’ team in the Netherlands acted as the exclusive M&A sell-side advisor to the shareholders of DierenDokters. This transaction em...
Read articleFEBRUARY DEAL ACTIVITY: Our activity followed a similar pace to what we saw in the first month of 2023 with 14 transactions closed, of which 13 wer...
Read articleJANUARY DEAL ACTIVITY: As we look to build on our 35+-year track record of helping clients navigate complex market conditions, January 2023 saw us ...
Read articleDEAL FLASH: The acquisition of MBI Healthcare Technologies by DNV AS demonstrates Oaklins’ ability to advise on complex international transactions ...
Read articleSUMMER DEAL ACTIVITY: The ongoing economic turmoil is impacting M&A markets but the appetite for M&A persists with 37 transactions closed in July a...
Read articleDEAL FLASH: The acquisition of Silverlink PCS Software Limited provides Alcidion Group Limited with a PAS capability, which is the foundational dat...
Read articleMONTHLY DEAL ACTIVITY: 2022 has got off to a good start for Oaklins with 36 closed transactions of which 34 were M&A deals and two were fundraising...
Read articleIn Oaklins Denmark we are proud of our strong results in 2021, and grateful for the trust that our existing and potential clients place in us. Acro...
Read articleMONTHLY DEAL ACTIVITY: In November 2021, we closed 40 transactions of which 31 were M&A deals and 9 were fundraising deals. The surge in deal activ...
Read articleMONTHLY DEAL ACTIVITY: In October 2021, we closed 27 transactions of which 20 were M&A deals and 7 were fundraising deals. We expect deal activity ...
Read articleDEAL FLASH: Ace Pharmaceuticals (Ace) has been acquired by a consortium of Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and Ace’s mana...
Read articleDEAL FLASH: Oaklins’ team in Lithuania acted as the sole sell-side financial advisor to CGP Management in the sale of MediCA klinika and Kardiolita...
Read articleDEAL FLASH: Enterprises ImportFab Inc. has been acquired by Labomar S.p.a, a leading Italian contract development manufacturing organization.
Read articleDEAL FLASH: Millbrook Healthcare, a leading provider of healthcare-related services, has been acquired by Cairngorm Capital, a specialist private i...
Read articleDEAL FLASH: MJH Associates, Inc. has acquired major market media assets from the UBM Life Sciences Group of Informa PLC. This acquisition creates t...
Read articleDEAL FLASH: Oaklins’ team in Italy has advised Lifco AB, a Swedish investment group, on the acquisition of a majority stake in Rhein83 Srl. Lifco a...
Read articleDEAL FLASH: Oaklins’ team in Germany has advised the private shareholders of Acutronic Group, a group on non-affiliated companies active in neonata...
Read articleDEAL FLASH: Oaklins’ team in Germany and our healthcare specialist in New York have advised the shareholders of Vascotube GmbH, a global manufactur...
Read article